Methods for treatment of cancer with an anti-tigit antagonist antibody
US-2024424092-A1 · Dec 26, 2024 · US
US11771676B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11771676-B2 |
| Application number | US-202318190372-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 27, 2023 |
| Priority date | Apr 29, 2022 |
| Publication date | Oct 3, 2023 |
| Grant date | Oct 3, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed is a method for preparing high-load oral paclitaxel capsule for a slow release in colon, belonging to the field of porous starch drug loading. The preparation method of the present disclosure includes the following steps: (1) dripping an ethanol solution of paclitaxel into a water phase and drying the solution to obtain an amorphous paclitaxel microsphere; (2) redissolving the paclitaxel microsphere prepared in step (1) in the ethanol solution, dispersing porous starch in the ethanol solution for adsorption, volatilizing a solvent in an oven, washing the porous starch with the ethanol solution to remove unadsorbed paclitaxel, and centrifuging same to obtain a precipitate, namely the porous starch loaded with paclitaxel; and (3) dispersing the porous starch loaded with paclitaxel prepared in step (2) in a chitosan solution, dropwise adding the solution into a phytic acid solution, and stirring the solution for 4 hours to obtain a coated capsule.
Opening claim text (preview).
What is claimed is: 1. A method for preparing a high-load oral paclitaxel capsule for slow release in colon, comprising the following steps: (1) preparing an amorphous paclitaxel: dripping an ethanol solution of paclitaxel into a water phase, and stirring uniformly and drying the solution to obtain an amorphous paclitaxel microsphere; (2) adsorbing paclitaxel with porous starch: redissolving the amorphous paclitaxel microsphere prepared in step (1) in the ethanol solution, dispersing porous starch in the ethanol solution for adsorption, volatilizing a solvent in an oven, washing the porous starch with the ethanol solution to remove unadsorbed paclitaxel, and centrifuging same to obtain a precipitate, namely the porous starch loaded with paclitaxel; and (3) preparing a chitosan-coated capsule: dispersing the porous starch loaded with paclitaxel prepared in step (2) in a chitosan solution, after dispersing uniformly to obtain a solution, dropwise adding the solution into a phytic acid solution, and stirring to obtain a coated capsule. 2. The method according to claim 1 , wherein a concentration of the paclitaxel in the ethanol solution of paclitaxel in step (1) is 10-20 mg/mL. 3. The method according to claim 1 , wherein a volume ratio of the water phase to the ethanol phase in step (1) is (2-4):1. 4. The method according to claim 1 , wherein a mass ratio of the porous starch to the paclitaxel microsphere in step (2) is (3-7):1. 5. The method according to claim 1 , wherein the volatilizing of the solvent is performed at a temperature of 40-55° C. for 10-20 minutes in step (2). 6. The method according to claim 1 , wherein a mass ratio of the porous starch loaded with paclitaxel to the chitosan in step (3) is (4-6):1. 7. The method according to claim 1 , wherein a volume ratio of the phytic acid solution to the chitosan solution in step (3) is (7-10):1. 8. The method according to claim 1 , wherein the chitosan solution in step (3) is an aqueous solution at a chitosan concentration of 30-50 mg/mL. 9. A high-load oral paclitaxel capsule prepared by the method according to claim 1 .
having four-membered rings, e.g. taxol · CPC title
Mouth and digestive tract, i.e. intraoral and peroral administration · CPC title
Organic macromolecular compounds · CPC title
Polysaccharides, e.g. gums, alginate; Cyclodextrin · CPC title
Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin (homeopathic globules A61K9/1623) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.